

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | outer ear morphogenesis (GO:0042473) | 5.24870969 |
| 2 | * skeletal muscle tissue development (GO:0007519) | 5.20865290 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 5.17479198 |
| 4 | response to muscle activity (GO:0014850) | 4.94532589 |
| 5 | negative regulation of fatty acid transport (GO:2000192) | 4.84867288 |
| 6 | * middle ear morphogenesis (GO:0042474) | 4.62889021 |
| 7 | plasma membrane repair (GO:0001778) | 4.62785843 |
| 8 | striated muscle contraction (GO:0006941) | 4.55073364 |
| 9 | actin-myosin filament sliding (GO:0033275) | 4.49015964 |
| 10 | muscle filament sliding (GO:0030049) | 4.49015964 |
| 11 | sarcomere organization (GO:0045214) | 4.43888806 |
| 12 | myofibril assembly (GO:0030239) | 4.41786969 |
| 13 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.22995969 |
| 14 | * embryonic cranial skeleton morphogenesis (GO:0048701) | 4.14111891 |
| 15 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.13440854 |
| 16 | actin-mediated cell contraction (GO:0070252) | 4.04990928 |
| 17 | skeletal muscle fiber development (GO:0048741) | 4.02080647 |
| 18 | muscle cell fate commitment (GO:0042693) | 3.99817292 |
| 19 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.89850174 |
| 20 | skeletal muscle contraction (GO:0003009) | 3.89135516 |
| 21 | hippo signaling (GO:0035329) | 3.88293406 |
| 22 | * striated muscle tissue development (GO:0014706) | 3.79875465 |
| 23 | collagen fibril organization (GO:0030199) | 3.76626170 |
| 24 | muscle contraction (GO:0006936) | 3.76022385 |
| 25 | cardiac myofibril assembly (GO:0055003) | 3.71138073 |
| 26 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.62974116 |
| 27 | * muscle tissue development (GO:0060537) | 3.61049393 |
| 28 | mitotic sister chromatid cohesion (GO:0007064) | 3.56221277 |
| 29 | regulation of relaxation of muscle (GO:1901077) | 3.56054909 |
| 30 | actomyosin structure organization (GO:0031032) | 3.55173099 |
| 31 | * regulation of cardioblast proliferation (GO:0003264) | 3.54903432 |
| 32 | * regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.54903432 |
| 33 | ganglion development (GO:0061548) | 3.53891620 |
| 34 | actin filament-based movement (GO:0030048) | 3.52035538 |
| 35 | glycogen catabolic process (GO:0005980) | 3.51965326 |
| 36 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.48918265 |
| 37 | bone trabecula formation (GO:0060346) | 3.47480860 |
| 38 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.45752766 |
| 39 | axon extension involved in axon guidance (GO:0048846) | 3.45752766 |
| 40 | proximal/distal pattern formation (GO:0009954) | 3.45447600 |
| 41 | glycogen biosynthetic process (GO:0005978) | 3.45298891 |
| 42 | glucan biosynthetic process (GO:0009250) | 3.45298891 |
| 43 | positive regulation of myotube differentiation (GO:0010831) | 3.42918411 |
| 44 | myoblast fusion (GO:0007520) | 3.39184434 |
| 45 | muscle organ morphogenesis (GO:0048644) | 3.37969241 |
| 46 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.35261320 |
| 47 | * muscle cell migration (GO:0014812) | 3.33668148 |
| 48 | muscle system process (GO:0003012) | 3.31308138 |
| 49 | syncytium formation (GO:0006949) | 3.31031213 |
| 50 | chondrocyte proliferation (GO:0035988) | 3.30711296 |
| 51 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.29239258 |
| 52 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.27196410 |
| 53 | myotube cell development (GO:0014904) | 3.25326083 |
| 54 | cardiac muscle contraction (GO:0060048) | 3.21364217 |
| 55 | muscle organ development (GO:0007517) | 3.19735221 |
| 56 | glucan catabolic process (GO:0009251) | 3.19206924 |
| 57 | * regulation of heart morphogenesis (GO:2000826) | 3.18942114 |
| 58 | face morphogenesis (GO:0060325) | 3.15936631 |
| 59 | muscle structure development (GO:0061061) | 3.15720302 |
| 60 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.15076502 |
| 61 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.14647568 |
| 62 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.13800474 |
| 63 | polarized epithelial cell differentiation (GO:0030859) | 3.12898263 |
| 64 | NADH metabolic process (GO:0006734) | 3.12411501 |
| 65 | skeletal muscle adaptation (GO:0043501) | 3.10998813 |
| 66 | peripheral nervous system neuron development (GO:0048935) | 3.06850327 |
| 67 | * metanephric mesenchyme development (GO:0072075) | 3.05922121 |
| 68 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.05408505 |
| 69 | creatine metabolic process (GO:0006600) | 2.98868575 |
| 70 | extracellular fibril organization (GO:0043206) | 2.98775497 |
| 71 | * aorta morphogenesis (GO:0035909) | 2.98563293 |
| 72 | paraxial mesoderm development (GO:0048339) | 2.96196475 |
| 73 | skeletal muscle tissue regeneration (GO:0043403) | 2.95823856 |
| 74 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.95515718 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.95171739 |
| 76 | striated muscle atrophy (GO:0014891) | 2.93363180 |
| 77 | negative regulation of cartilage development (GO:0061037) | 2.91308834 |
| 78 | cellular polysaccharide catabolic process (GO:0044247) | 2.88562573 |
| 79 | response to inactivity (GO:0014854) | 2.88402903 |
| 80 | segment specification (GO:0007379) | 2.88201193 |
| 81 | regulation of cardioblast differentiation (GO:0051890) | 2.88180493 |
| 82 | muscle atrophy (GO:0014889) | 2.87647565 |
| 83 | positive regulation of actin filament depolymerization (GO:0030836) | 2.85769459 |
| 84 | craniofacial suture morphogenesis (GO:0097094) | 2.84987573 |
| 85 | negative regulation of cell size (GO:0045792) | 2.84964452 |
| 86 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.84486795 |
| 87 | negative regulation of embryonic development (GO:0045992) | 2.84083070 |
| 88 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.83843332 |
| 89 | positive regulation of myoblast differentiation (GO:0045663) | 2.82661469 |
| 90 | endodermal cell differentiation (GO:0035987) | 2.82357878 |
| 91 | muscle tissue morphogenesis (GO:0060415) | 2.81726976 |
| 92 | * kidney mesenchyme development (GO:0072074) | 2.81329166 |
| 93 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.79105249 |
| 94 | * generation of neurons (GO:0048699) | 2.78983184 |
| 95 | striated muscle adaptation (GO:0014888) | 2.78270704 |
| 96 | embryonic forelimb morphogenesis (GO:0035115) | 2.77472067 |
| 97 | protein heterotrimerization (GO:0070208) | 2.77244974 |
| 98 | * regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.77109086 |
| 99 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.76842211 |
| 100 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.76420666 |
| 101 | axonemal dynein complex assembly (GO:0070286) | 2.75344411 |
| 102 | forelimb morphogenesis (GO:0035136) | 2.72848565 |
| 103 | motile cilium assembly (GO:0044458) | 2.72271680 |
| 104 | AMP metabolic process (GO:0046033) | 2.72248594 |
| 105 | tricarboxylic acid cycle (GO:0006099) | 2.71233158 |
| 106 | myotube differentiation (GO:0014902) | 2.71201780 |
| 107 | bone morphogenesis (GO:0060349) | 2.70618952 |
| 108 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.69942385 |
| 109 | lymph vessel development (GO:0001945) | 2.69104774 |
| 110 | * positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.69002757 |
| 111 | negative regulation of cell fate specification (GO:0009996) | 2.68642133 |
| 112 | body morphogenesis (GO:0010171) | 2.68549482 |
| 113 | mesenchyme morphogenesis (GO:0072132) | 2.68526929 |
| 114 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.67609161 |
| 115 | embryonic body morphogenesis (GO:0010172) | 2.64714031 |
| 116 | gluconeogenesis (GO:0006094) | 2.62726440 |
| 117 | striated muscle cell development (GO:0055002) | 2.62199423 |
| 118 | Golgi transport vesicle coating (GO:0048200) | 2.61597441 |
| 119 | COPI coating of Golgi vesicle (GO:0048205) | 2.61597441 |
| 120 | chondrocyte development (GO:0002063) | 2.61508001 |
| 121 | endocardial cushion development (GO:0003197) | 2.61114152 |
| 122 | muscle cell proliferation (GO:0033002) | 2.60894435 |
| 123 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.60865935 |
| 124 | negative regulation of protein localization to cell surface (GO:2000009) | 2.60100167 |
| 125 | cell-substrate adherens junction assembly (GO:0007045) | 2.59802688 |
| 126 | focal adhesion assembly (GO:0048041) | 2.59802688 |
| 127 | non-canonical Wnt signaling pathway (GO:0035567) | 2.58980374 |
| 128 | regulation of myoblast differentiation (GO:0045661) | 2.55759025 |
| 129 | convergent extension (GO:0060026) | 2.55205237 |
| 130 | hemidesmosome assembly (GO:0031581) | 2.55198928 |
| 131 | glycogen metabolic process (GO:0005977) | 2.54460043 |
| 132 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.54125263 |
| 133 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.53705055 |
| 134 | mitotic chromosome condensation (GO:0007076) | 2.53459536 |
| 135 | * myoblast migration (GO:0051451) | 2.53216384 |
| 136 | regulation of establishment of planar polarity (GO:0090175) | 2.53140083 |
| 137 | face development (GO:0060324) | 2.52481738 |
| 138 | polysaccharide catabolic process (GO:0000272) | 2.52164910 |
| 139 | cellular response to interferon-alpha (GO:0035457) | 2.51536603 |
| 140 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.51186687 |
| 141 | cardiac muscle cell development (GO:0055013) | 2.50392010 |
| 142 | * cochlea morphogenesis (GO:0090103) | 2.49476792 |
| 143 | regulation of cell communication by electrical coupling (GO:0010649) | 2.49013508 |
| 144 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.48343340 |
| 145 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.48214474 |
| 146 | glycoprotein catabolic process (GO:0006516) | 2.46834669 |
| 147 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.46539229 |
| 148 | positive regulation of skeletal muscle tissue development (GO:0048643) | 2.46396285 |
| 149 | camera-type eye morphogenesis (GO:0048593) | 2.45786351 |
| 150 | negative regulation of catenin import into nucleus (GO:0035414) | 2.45297216 |
| 151 | endocrine hormone secretion (GO:0060986) | 2.45078828 |
| 152 | * mesenchyme development (GO:0060485) | 2.44661038 |
| 153 | eye morphogenesis (GO:0048592) | 2.44035538 |
| 154 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.42511823 |
| 155 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.40398260 |
| 156 | * embryonic skeletal system morphogenesis (GO:0048704) | 2.40289468 |
| 157 | regulation of protein heterodimerization activity (GO:0043497) | 2.39532261 |
| 158 | * regulation of mesenchymal cell proliferation (GO:0010464) | 2.39424336 |
| 159 | regulation of cartilage development (GO:0061035) | 2.37919380 |
| 160 | muscle fiber development (GO:0048747) | 2.36879336 |
| 161 | muscle cell cellular homeostasis (GO:0046716) | 2.36221956 |
| 162 | notochord development (GO:0030903) | 2.34557854 |
| 163 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.32217051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.29548700 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.28697771 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.22444033 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.81123828 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.41504249 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.22121385 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.06464603 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05218912 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.87757302 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87610241 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.65455219 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.51061640 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.43285369 |
| 14 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.42551168 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34783237 |
| 16 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.29352178 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26484370 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.24867716 |
| 19 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.18281505 |
| 20 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.09632639 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.08804727 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.06003186 |
| 23 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.04060660 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.02606145 |
| 25 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.99296736 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.97134000 |
| 27 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.95125279 |
| 28 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.94960051 |
| 29 | CJUN_26792858_Chip-Seq_BT549_Human | 1.94325859 |
| 30 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.90335487 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.89560076 |
| 32 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.88978501 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.88090139 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83739452 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.80721649 |
| 36 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79310700 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78602501 |
| 38 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.76971099 |
| 39 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.76971099 |
| 40 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.76632426 |
| 41 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.73751240 |
| 42 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.73492909 |
| 43 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.71785876 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68597002 |
| 45 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.67969742 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.65742178 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64967441 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64570085 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61755453 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.60510168 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.60510168 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57847913 |
| 53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.57321968 |
| 54 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.56911664 |
| 55 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.56911664 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56089838 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54699692 |
| 58 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.54365508 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.53588179 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.52717638 |
| 61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.51436853 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.48054950 |
| 63 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.46817931 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42047762 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35231197 |
| 66 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.33007204 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32978989 |
| 68 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.31697742 |
| 69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29748042 |
| 70 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29321078 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28305042 |
| 72 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28144481 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27802626 |
| 74 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27732396 |
| 75 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.26725808 |
| 76 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.26275653 |
| 77 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26265694 |
| 78 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.25076750 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24251872 |
| 80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24034842 |
| 81 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.23168677 |
| 82 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23094262 |
| 83 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.22002099 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20662388 |
| 85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20178456 |
| 86 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.19586628 |
| 87 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18954118 |
| 88 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18133966 |
| 89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17458708 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17351638 |
| 91 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.16947744 |
| 92 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16108598 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14678228 |
| 94 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.14599750 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14532376 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14439440 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14372621 |
| 98 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13647845 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.12849773 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11139357 |
| 101 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09636058 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09500323 |
| 103 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09379767 |
| 104 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09379767 |
| 105 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08920575 |
| 106 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08560196 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07414059 |
| 108 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06317969 |
| 109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06098285 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05357691 |
| 111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.05237107 |
| 112 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04466946 |
| 113 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.04364040 |
| 114 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03230715 |
| 115 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03122697 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01857407 |
| 117 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01275509 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01233753 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01135849 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00844609 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00519545 |
| 122 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00193423 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00172569 |
| 124 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99932380 |
| 125 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.97311650 |
| 126 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97179564 |
| 127 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.97135587 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97115651 |
| 129 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96899402 |
| 130 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96687932 |
| 131 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95946837 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95431603 |
| 133 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95179236 |
| 134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94084888 |
| 135 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.94006673 |
| 136 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93921582 |
| 137 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93757000 |
| 138 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.93412885 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93373463 |
| 140 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.92067174 |
| 141 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91922891 |
| 142 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.91590394 |
| 143 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91574910 |
| 144 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.91136969 |
| 145 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.90968742 |
| 146 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90802709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005503_abnormal_tendon_morphology | 3.72415388 |
| 2 | MP0003646_muscle_fatigue | 3.69402078 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.61616403 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.35103324 |
| 5 | * MP0000733_abnormal_muscle_development | 3.10835700 |
| 6 | MP0009250_abnormal_appendicular_skeleto | 2.79531105 |
| 7 | * MP0010030_abnormal_orbit_morphology | 2.65431621 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.63264306 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.60711075 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.48396320 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.48227570 |
| 12 | MP0005275_abnormal_skin_tensile | 2.31755336 |
| 13 | MP0002249_abnormal_larynx_morphology | 2.23186449 |
| 14 | MP0000749_muscle_degeneration | 2.13092501 |
| 15 | MP0003385_abnormal_body_wall | 2.05161882 |
| 16 | MP0005330_cardiomyopathy | 2.01479146 |
| 17 | MP0003937_abnormal_limbs/digits/tail_de | 1.98889587 |
| 18 | * MP0003755_abnormal_palate_morphology | 1.98880392 |
| 19 | MP0000751_myopathy | 1.94013548 |
| 20 | * MP0000049_abnormal_middle_ear | 1.91394145 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 1.89513783 |
| 22 | MP0000750_abnormal_muscle_regeneration | 1.88831417 |
| 23 | MP0002108_abnormal_muscle_morphology | 1.88526429 |
| 24 | MP0002332_abnormal_exercise_endurance | 1.86121772 |
| 25 | * MP0001346_abnormal_lacrimal_gland | 1.84902011 |
| 26 | MP0005508_abnormal_skeleton_morphology | 1.84002436 |
| 27 | MP0000678_abnormal_parathyroid_gland | 1.83851712 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.83008451 |
| 29 | MP0004084_abnormal_cardiac_muscle | 1.82731488 |
| 30 | * MP0000759_abnormal_skeletal_muscle | 1.81266030 |
| 31 | MP0009053_abnormal_anal_canal | 1.78529655 |
| 32 | MP0004130_abnormal_muscle_cell | 1.75251087 |
| 33 | MP0002254_reproductive_system_inflammat | 1.74239710 |
| 34 | * MP0001299_abnormal_eye_distance/ | 1.74080423 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.70282969 |
| 36 | MP0005451_abnormal_body_composition | 1.67867327 |
| 37 | MP0002009_preneoplasia | 1.65928990 |
| 38 | * MP0003942_abnormal_urinary_system | 1.60433348 |
| 39 | * MP0000762_abnormal_tongue_morphology | 1.59325294 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.58604096 |
| 41 | MP0000428_abnormal_craniofacial_morphol | 1.56039460 |
| 42 | MP0005367_renal/urinary_system_phenotyp | 1.55003077 |
| 43 | MP0000516_abnormal_urinary_system | 1.55003077 |
| 44 | * MP0004087_abnormal_muscle_fiber | 1.54307711 |
| 45 | * MP0002233_abnormal_nose_morphology | 1.54074852 |
| 46 | MP0002106_abnormal_muscle_physiology | 1.53899934 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.53277576 |
| 48 | MP0005369_muscle_phenotype | 1.52674021 |
| 49 | MP0003279_aneurysm | 1.52296178 |
| 50 | * MP0002932_abnormal_joint_morphology | 1.51242749 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.48517908 |
| 52 | MP0005670_abnormal_white_adipose | 1.46643564 |
| 53 | * MP0000534_abnormal_ureter_morphology | 1.46490041 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.46031097 |
| 55 | MP0000747_muscle_weakness | 1.45745979 |
| 56 | MP0009384_cardiac_valve_regurgitation | 1.43375696 |
| 57 | * MP0003935_abnormal_craniofacial_develop | 1.38257875 |
| 58 | MP0002972_abnormal_cardiac_muscle | 1.36980587 |
| 59 | MP0000537_abnormal_urethra_morphology | 1.34868466 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.34261502 |
| 61 | MP0005023_abnormal_wound_healing | 1.32299014 |
| 62 | MP0003941_abnormal_skin_development | 1.32039290 |
| 63 | MP0002896_abnormal_bone_mineralization | 1.31818327 |
| 64 | MP0001849_ear_inflammation | 1.31504409 |
| 65 | MP0003091_abnormal_cell_migration | 1.29359246 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.27571561 |
| 67 | MP0005248_abnormal_Harderian_gland | 1.26657346 |
| 68 | MP0004134_abnormal_chest_morphology | 1.26259784 |
| 69 | * MP0002116_abnormal_craniofacial_bone | 1.25902378 |
| 70 | MP0004233_abnormal_muscle_weight | 1.22708562 |
| 71 | MP0002269_muscular_atrophy | 1.21240068 |
| 72 | * MP0002109_abnormal_limb_morphology | 1.20705756 |
| 73 | MP0000432_abnormal_head_morphology | 1.19666292 |
| 74 | * MP0000163_abnormal_cartilage_morphology | 1.19589290 |
| 75 | MP0002115_abnormal_skeleton_extremities | 1.19390942 |
| 76 | MP0005187_abnormal_penis_morphology | 1.16088136 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.14781560 |
| 78 | MP0010307_abnormal_tumor_latency | 1.13930019 |
| 79 | MP0000681_abnormal_thyroid_gland | 1.13415931 |
| 80 | MP0001542_abnormal_bone_strength | 1.13087094 |
| 81 | * MP0008789_abnormal_olfactory_epithelium | 1.12693376 |
| 82 | MP0002971_abnormal_brown_adipose | 1.12126873 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 1.10843353 |
| 84 | MP0002060_abnormal_skin_morphology | 1.10581866 |
| 85 | MP0009278_abnormal_bone_marrow | 1.10201063 |
| 86 | MP0001879_abnormal_lymphatic_vessel | 1.09537837 |
| 87 | MP0001661_extended_life_span | 1.08357153 |
| 88 | MP0004272_abnormal_basement_membrane | 1.05038807 |
| 89 | MP0006138_congestive_heart_failure | 1.04923920 |
| 90 | * MP0002114_abnormal_axial_skeleton | 1.02609781 |
| 91 | * MP0002113_abnormal_skeleton_development | 1.02266511 |
| 92 | MP0002111_abnormal_tail_morphology | 1.01930570 |
| 93 | MP0005499_abnormal_olfactory_system | 0.99442394 |
| 94 | MP0005394_taste/olfaction_phenotype | 0.99442394 |
| 95 | MP0002938_white_spotting | 0.97026521 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 0.96498346 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.96373437 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.95186224 |
| 99 | MP0002282_abnormal_trachea_morphology | 0.94786235 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.94781938 |
| 101 | * MP0002177_abnormal_outer_ear | 0.92982370 |
| 102 | * MP0001270_distended_abdomen | 0.91988051 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.91750722 |
| 104 | MP0001958_emphysema | 0.91270844 |
| 105 | MP0005390_skeleton_phenotype | 0.91252658 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.85989421 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.85403654 |
| 108 | MP0003878_abnormal_ear_physiology | 0.85403654 |
| 109 | MP0003315_abnormal_perineum_morphology | 0.85096265 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.84692417 |
| 111 | MP0005385_cardiovascular_system_phenoty | 0.82729301 |
| 112 | MP0001544_abnormal_cardiovascular_syste | 0.82729301 |
| 113 | MP0009703_decreased_birth_body | 0.81383545 |
| 114 | MP0010630_abnormal_cardiac_muscle | 0.80990242 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.79096403 |
| 116 | MP0000383_abnormal_hair_follicle | 0.77998717 |
| 117 | MP0003828_pulmonary_edema | 0.76959742 |
| 118 | MP0002084_abnormal_developmental_patter | 0.76286403 |
| 119 | MP0003115_abnormal_respiratory_system | 0.74600681 |
| 120 | * MP0002085_abnormal_embryonic_tissue | 0.74448236 |
| 121 | MP0005620_abnormal_muscle_contractility | 0.74442696 |
| 122 | MP0004215_abnormal_myocardial_fiber | 0.73804152 |
| 123 | MP0002925_abnormal_cardiovascular_devel | 0.73676269 |
| 124 | MP0000266_abnormal_heart_morphology | 0.73499435 |
| 125 | MP0004185_abnormal_adipocyte_glucose | 0.72930857 |
| 126 | MP0008007_abnormal_cellular_replicative | 0.72219605 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.70903885 |
| 128 | MP0002697_abnormal_eye_size | 0.70699761 |
| 129 | MP0002160_abnormal_reproductive_system | 0.68934331 |
| 130 | MP0003879_abnormal_hair_cell | 0.67845353 |
| 131 | MP0005266_abnormal_metabolism | 0.65645133 |
| 132 | MP0004858_abnormal_nervous_system | 0.64441138 |
| 133 | MP0002128_abnormal_blood_circulation | 0.62221046 |
| 134 | MP0005197_abnormal_uvea_morphology | 0.55339635 |
| 135 | MP0004484_altered_response_of | 0.54391423 |
| 136 | MP0000467_abnormal_esophagus_morphology | 0.53966016 |
| 137 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53593365 |
| 138 | MP0004510_myositis | 0.52180060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.26497163 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.20535961 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 5.15452256 |
| 4 | Nemaline bodies (HP:0003798) | 4.69407806 |
| 5 | Distal arthrogryposis (HP:0005684) | 4.62917438 |
| 6 | Popliteal pterygium (HP:0009756) | 3.87864696 |
| 7 | Round ear (HP:0100830) | 3.78771910 |
| 8 | Absent phalangeal crease (HP:0006109) | 3.63657539 |
| 9 | Protrusio acetabuli (HP:0003179) | 3.61452231 |
| 10 | Neck muscle weakness (HP:0000467) | 3.58067342 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.50203332 |
| 12 | Rhabdomyolysis (HP:0003201) | 3.50006859 |
| 13 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.46811775 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 3.44027190 |
| 15 | Myoglobinuria (HP:0002913) | 3.42671461 |
| 16 | Deformed tarsal bones (HP:0008119) | 3.31989884 |
| 17 | Calcaneovalgus deformity (HP:0001848) | 3.31294744 |
| 18 | Increased connective tissue (HP:0009025) | 3.22121977 |
| 19 | Malignant hyperthermia (HP:0002047) | 3.14192309 |
| 20 | Scapular winging (HP:0003691) | 3.11623213 |
| 21 | Difficulty running (HP:0009046) | 3.05197494 |
| 22 | Shallow orbits (HP:0000586) | 3.00937203 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 2.98228014 |
| 24 | Myopathic facies (HP:0002058) | 2.92165033 |
| 25 | Rimmed vacuoles (HP:0003805) | 2.89334179 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 2.88769029 |
| 27 | Exercise-induced muscle cramps (HP:0003710) | 2.86207645 |
| 28 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.85143080 |
| 29 | Short 4th metacarpal (HP:0010044) | 2.85143080 |
| 30 | Muscle stiffness (HP:0003552) | 2.84759325 |
| 31 | Arterial tortuosity (HP:0005116) | 2.77972077 |
| 32 | Difficulty climbing stairs (HP:0003551) | 2.77921841 |
| 33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.76809310 |
| 34 | Subaortic stenosis (HP:0001682) | 2.76809310 |
| 35 | Pterygium (HP:0001059) | 2.74513213 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 2.70176683 |
| 37 | Vascular tortuosity (HP:0004948) | 2.70026340 |
| 38 | Microglossia (HP:0000171) | 2.64880488 |
| 39 | Limb-girdle muscle atrophy (HP:0003797) | 2.63768238 |
| 40 | Fatigable weakness (HP:0003473) | 2.63436922 |
| 41 | Abnormality of the neuromuscular junction (HP:0003398) | 2.63436922 |
| 42 | Infantile muscular hypotonia (HP:0008947) | 2.62383317 |
| 43 | Pelvic girdle muscle weakness (HP:0003749) | 2.60964771 |
| 44 | Muscle fiber splitting (HP:0003555) | 2.59033061 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.58853959 |
| 46 | Spinal rigidity (HP:0003306) | 2.56907423 |
| 47 | Hypoplastic ischia (HP:0003175) | 2.56128542 |
| 48 | Bell-shaped thorax (HP:0001591) | 2.54989886 |
| 49 | Exercise-induced myalgia (HP:0003738) | 2.51782377 |
| 50 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.49931605 |
| 51 | Abnormality of the calf musculature (HP:0001430) | 2.49687125 |
| 52 | Abnormality of the calcaneus (HP:0008364) | 2.49659211 |
| 53 | Ankle contracture (HP:0006466) | 2.48191932 |
| 54 | Myotonia (HP:0002486) | 2.42946727 |
| 55 | Abnormality of the ischium (HP:0003174) | 2.42900406 |
| 56 | Slender build (HP:0001533) | 2.41418135 |
| 57 | Hip contracture (HP:0003273) | 2.38578252 |
| 58 | Mesomelia (HP:0003027) | 2.37082823 |
| 59 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.36769363 |
| 60 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.36769363 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.36683872 |
| 62 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.35198096 |
| 63 | Calf muscle hypertrophy (HP:0008981) | 2.33958599 |
| 64 | Long clavicles (HP:0000890) | 2.32661940 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.27123719 |
| 66 | Knee flexion contracture (HP:0006380) | 2.26936604 |
| 67 | Increased density of long bones (HP:0006392) | 2.26465499 |
| 68 | Bulbar palsy (HP:0001283) | 2.24995171 |
| 69 | EMG: myopathic abnormalities (HP:0003458) | 2.24994200 |
| 70 | Shoulder girdle muscle weakness (HP:0003547) | 2.24004015 |
| 71 | Tarsal synostosis (HP:0008368) | 2.23123677 |
| 72 | Atrophic scars (HP:0001075) | 2.22421801 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20866249 |
| 74 | Wrist flexion contracture (HP:0001239) | 2.19564923 |
| 75 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.16971568 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15067270 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.15067270 |
| 78 | Abnormality of the 4th metacarpal (HP:0010012) | 2.14987844 |
| 79 | Areflexia of lower limbs (HP:0002522) | 2.13124266 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.11856605 |
| 81 | Metatarsus adductus (HP:0001840) | 2.09036657 |
| 82 | Spinal cord lesions (HP:0100561) | 2.08446377 |
| 83 | Syringomyelia (HP:0003396) | 2.08446377 |
| 84 | Limited hip movement (HP:0008800) | 2.08285471 |
| 85 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.08179890 |
| 86 | Sudden death (HP:0001699) | 2.07811744 |
| 87 | Soft skin (HP:0000977) | 2.07221791 |
| 88 | Abnormality of placental membranes (HP:0011409) | 2.06723992 |
| 89 | Amniotic constriction ring (HP:0009775) | 2.06723992 |
| 90 | Lipoatrophy (HP:0100578) | 2.03789478 |
| 91 | Frequent falls (HP:0002359) | 2.03301176 |
| 92 | Down-sloping shoulders (HP:0200021) | 2.02841620 |
| 93 | Weak cry (HP:0001612) | 2.01526054 |
| 94 | Generalized amyotrophy (HP:0003700) | 2.01475669 |
| 95 | Short palpebral fissure (HP:0012745) | 2.00559899 |
| 96 | Limb-girdle muscle weakness (HP:0003325) | 2.00407433 |
| 97 | Fragile skin (HP:0001030) | 1.97982334 |
| 98 | Synostosis involving bones of the feet (HP:0009140) | 1.96737210 |
| 99 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.96737210 |
| 100 | Mixed hearing impairment (HP:0000410) | 1.95443706 |
| 101 | Bundle branch block (HP:0011710) | 1.95222767 |
| 102 | Thin ribs (HP:0000883) | 1.93881217 |
| 103 | Wormian bones (HP:0002645) | 1.93068589 |
| 104 | Aortic dissection (HP:0002647) | 1.93061151 |
| 105 | Asymmetry of the thorax (HP:0001555) | 1.92253673 |
| 106 | Breech presentation (HP:0001623) | 1.91300910 |
| 107 | Type 2 muscle fiber atrophy (HP:0003554) | 1.91038927 |
| 108 | Abnormal atrioventricular conduction (HP:0005150) | 1.90894323 |
| 109 | Muscle fiber atrophy (HP:0100295) | 1.90487427 |
| 110 | Aplasia of the musculature (HP:0100854) | 1.89558764 |
| 111 | Elbow flexion contracture (HP:0002987) | 1.89176536 |
| 112 | Progressive muscle weakness (HP:0003323) | 1.88228900 |
| 113 | Chin dimple (HP:0010751) | 1.87339381 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 1.86635236 |
| 115 | Deviation of the hallux (HP:0010051) | 1.86284525 |
| 116 | Dilated cardiomyopathy (HP:0001644) | 1.85761626 |
| 117 | EMG: neuropathic changes (HP:0003445) | 1.83627564 |
| 118 | Dilatation of the ascending aorta (HP:0005111) | 1.83043519 |
| 119 | Ulnar deviation of finger (HP:0009465) | 1.82101711 |
| 120 | Camptodactyly of toe (HP:0001836) | 1.81917460 |
| 121 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.81540226 |
| 122 | Spondylolisthesis (HP:0003302) | 1.80479005 |
| 123 | Hallux valgus (HP:0001822) | 1.79965788 |
| 124 | Distal lower limb muscle weakness (HP:0009053) | 1.79780388 |
| 125 | Abnormality of dentin (HP:0010299) | 1.79372540 |
| 126 | Cervical subluxation (HP:0003308) | 1.77946771 |
| 127 | Natal tooth (HP:0000695) | 1.76402765 |
| 128 | Atrioventricular block (HP:0001678) | 1.76363956 |
| 129 | Aortic aneurysm (HP:0004942) | 1.76127595 |
| 130 | Broad metatarsal (HP:0001783) | 1.76010292 |
| 131 | Heart block (HP:0012722) | 1.75748406 |
| 132 | Gowers sign (HP:0003391) | 1.74916407 |
| 133 | Bladder diverticulum (HP:0000015) | 1.73546143 |
| 134 | Proximal amyotrophy (HP:0007126) | 1.73543078 |
| 135 | Hyperkalemia (HP:0002153) | 1.73042679 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.72961011 |
| 137 | Muscular dystrophy (HP:0003560) | 1.71173227 |
| 138 | Abnormality of the umbilical cord (HP:0010881) | 1.71136515 |
| 139 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.66572587 |
| 140 | Abnormal delivery (HP:0001787) | 1.65732623 |
| 141 | Nonprogressive disorder (HP:0003680) | 1.65162910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 4.55535736 |
| 2 | TTN | 4.43131664 |
| 3 | EPHA3 | 3.97112216 |
| 4 | TRIB3 | 3.73707658 |
| 5 | LATS1 | 3.45556314 |
| 6 | OBSCN | 2.83299781 |
| 7 | ERBB3 | 2.55947673 |
| 8 | TRPM7 | 2.47886412 |
| 9 | PDGFRA | 2.05147162 |
| 10 | CDK6 | 1.97966577 |
| 11 | SIK1 | 1.83114360 |
| 12 | EPHA2 | 1.79338881 |
| 13 | MOS | 1.78872344 |
| 14 | NEK9 | 1.78690376 |
| 15 | PIK3CG | 1.76344940 |
| 16 | RIPK1 | 1.75381883 |
| 17 | PKN2 | 1.74038785 |
| 18 | ZAK | 1.73837982 |
| 19 | STK3 | 1.68247461 |
| 20 | LATS2 | 1.57754233 |
| 21 | VRK2 | 1.54063683 |
| 22 | LIMK1 | 1.53445195 |
| 23 | EPHB2 | 1.49627937 |
| 24 | CDK12 | 1.44859435 |
| 25 | EPHB1 | 1.39760855 |
| 26 | RPS6KA4 | 1.35640480 |
| 27 | DYRK1B | 1.34787583 |
| 28 | PHKG1 | 1.33186028 |
| 29 | PHKG2 | 1.33186028 |
| 30 | MAP2K3 | 1.29178720 |
| 31 | PTK6 | 1.26805649 |
| 32 | TESK1 | 1.23086240 |
| 33 | DMPK | 1.22789474 |
| 34 | RPS6KB2 | 1.19045858 |
| 35 | ICK | 1.16730934 |
| 36 | NME2 | 1.14234415 |
| 37 | MAP3K10 | 1.14091999 |
| 38 | FER | 1.11579824 |
| 39 | SMG1 | 1.07043507 |
| 40 | MYLK | 1.06694922 |
| 41 | NEK1 | 1.04506242 |
| 42 | MAP2K1 | 1.04243212 |
| 43 | FGFR3 | 1.00879577 |
| 44 | EEF2K | 0.98733127 |
| 45 | LRRK2 | 0.97029603 |
| 46 | MAPK12 | 0.96515967 |
| 47 | BMX | 0.93411676 |
| 48 | FGFR1 | 0.90864087 |
| 49 | CCNB1 | 0.90674300 |
| 50 | CDC7 | 0.88280978 |
| 51 | PAK4 | 0.86159124 |
| 52 | NEK2 | 0.83805207 |
| 53 | MAPKAPK3 | 0.83688892 |
| 54 | MTOR | 0.82888009 |
| 55 | MAPK15 | 0.82544813 |
| 56 | MUSK | 0.81413245 |
| 57 | MAP3K12 | 0.81155860 |
| 58 | MAP3K2 | 0.80362374 |
| 59 | TGFBR1 | 0.78949182 |
| 60 | NME1 | 0.76553036 |
| 61 | PTK2 | 0.76117710 |
| 62 | PAK2 | 0.74658904 |
| 63 | MAP3K3 | 0.74047409 |
| 64 | MST1R | 0.73252567 |
| 65 | BUB1 | 0.72303082 |
| 66 | FGFR4 | 0.72120495 |
| 67 | ILK | 0.71933052 |
| 68 | HIPK2 | 0.71871423 |
| 69 | IRAK3 | 0.71469526 |
| 70 | STK38 | 0.69249380 |
| 71 | CDK8 | 0.68916492 |
| 72 | ERBB4 | 0.68189426 |
| 73 | FRK | 0.67365122 |
| 74 | PIM2 | 0.65923651 |
| 75 | NUAK1 | 0.65896180 |
| 76 | NTRK1 | 0.65485929 |
| 77 | CAMK2G | 0.64096416 |
| 78 | TLK1 | 0.63033118 |
| 79 | TAOK2 | 0.62289853 |
| 80 | MAP3K7 | 0.61145367 |
| 81 | PRKAA2 | 0.59913581 |
| 82 | PDGFRB | 0.59902800 |
| 83 | PDK2 | 0.59723143 |
| 84 | MELK | 0.57814085 |
| 85 | PIK3CA | 0.56041126 |
| 86 | SCYL2 | 0.55671521 |
| 87 | AKT2 | 0.53514111 |
| 88 | MAP3K8 | 0.52362308 |
| 89 | MKNK1 | 0.51966234 |
| 90 | MAPK7 | 0.51850169 |
| 91 | ROCK1 | 0.50821251 |
| 92 | PBK | 0.50595395 |
| 93 | ERBB2 | 0.49693082 |
| 94 | YES1 | 0.49228695 |
| 95 | ABL2 | 0.48975942 |
| 96 | CHUK | 0.48428299 |
| 97 | BCKDK | 0.48282187 |
| 98 | AURKB | 0.47562589 |
| 99 | STK16 | 0.47124571 |
| 100 | PAK3 | 0.46950214 |
| 101 | PNCK | 0.46557482 |
| 102 | PAK6 | 0.45911451 |
| 103 | MAPK11 | 0.44537091 |
| 104 | RET | 0.43879621 |
| 105 | WNK1 | 0.42916363 |
| 106 | CDK9 | 0.42662073 |
| 107 | ARAF | 0.42505436 |
| 108 | PLK3 | 0.40715634 |
| 109 | PRKD2 | 0.39892140 |
| 110 | EIF2AK1 | 0.39604543 |
| 111 | PRKAA1 | 0.39514668 |
| 112 | CDK7 | 0.37784459 |
| 113 | JAK1 | 0.37681926 |
| 114 | MAPKAPK2 | 0.37472133 |
| 115 | KSR2 | 0.37302340 |
| 116 | ROCK2 | 0.36449101 |
| 117 | STK24 | 0.35689379 |
| 118 | BCR | 0.35672027 |
| 119 | MET | 0.35273486 |
| 120 | FGFR2 | 0.35150190 |
| 121 | TGFBR2 | 0.34679101 |
| 122 | DYRK3 | 0.34587573 |
| 123 | TTK | 0.34021870 |
| 124 | RPS6KA2 | 0.33887774 |
| 125 | MKNK2 | 0.33558684 |
| 126 | TAF1 | 0.32324592 |
| 127 | STK10 | 0.32314653 |
| 128 | STK38L | 0.32007492 |
| 129 | FLT3 | 0.31760669 |
| 130 | ALK | 0.31272771 |
| 131 | PTK2B | 0.31265353 |
| 132 | BMPR1B | 0.31090707 |
| 133 | NLK | 0.31069251 |
| 134 | BRSK1 | 0.30123812 |
| 135 | RPS6KC1 | 0.30018512 |
| 136 | RPS6KL1 | 0.30018512 |
| 137 | AURKA | 0.29772280 |
| 138 | PAK1 | 0.29675909 |
| 139 | AKT3 | 0.28727565 |
| 140 | MAP2K2 | 0.28229271 |
| 141 | PRKG1 | 0.27750533 |
| 142 | PIM1 | 0.27461186 |
| 143 | CDK14 | 0.27327507 |
| 144 | RPS6KA5 | 0.27098898 |
| 145 | CAMK2D | 0.26998394 |
| 146 | PRPF4B | 0.25574137 |
| 147 | MAP2K4 | 0.24070034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.19907268 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.11969255 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.31675734 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.30621781 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 2.19273564 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.10162525 |
| 7 | Focal adhesion_Homo sapiens_hsa04510 | 2.00927796 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.98826687 |
| 9 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.97947316 |
| 10 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.97404058 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95920514 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.95584845 |
| 13 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.92963345 |
| 14 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.92380889 |
| 15 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.87057421 |
| 16 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.76936430 |
| 17 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.75316366 |
| 18 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.75278924 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.73873671 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73081097 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70511883 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.70044134 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.68235382 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64564570 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.63534990 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.58640294 |
| 27 | Prostate cancer_Homo sapiens_hsa05215 | 1.49614597 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.47260484 |
| 29 | Melanoma_Homo sapiens_hsa05218 | 1.46605589 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46298721 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.45312552 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42698998 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.42565678 |
| 34 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.40216590 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.39904448 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.38847962 |
| 37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.36141840 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33012920 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32992832 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29681893 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29013286 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27730912 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 1.27361270 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25765149 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25665350 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24718782 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.24707823 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23572967 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21854862 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.20633235 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19995130 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.17068737 |
| 53 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.14867732 |
| 54 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.14648277 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13747110 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11836155 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11764092 |
| 58 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10331345 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08365502 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.08026355 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.06846083 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 1.06605934 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06266026 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05899201 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 1.05540041 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05107760 |
| 67 | Pathways in cancer_Homo sapiens_hsa05200 | 1.03522298 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03434662 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03240650 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01726894 |
| 71 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.01622471 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99888166 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99761890 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99647246 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97991892 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.96561050 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95509250 |
| 78 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.93974149 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.91876901 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.91508692 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90692704 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90529914 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90462910 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90316796 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.90138576 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89484855 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87748425 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87259465 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85768718 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84070807 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.83892469 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83135236 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82810522 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82781817 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82206168 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82108016 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80048301 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79616064 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78493089 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78448140 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.77070698 |
| 102 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76598336 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.74013115 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73586136 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73468026 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73173442 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72768074 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.72730481 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72558429 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72100819 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71929235 |
| 112 | Axon guidance_Homo sapiens_hsa04360 | 0.71863029 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69888541 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68513855 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67999418 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67797017 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.67350516 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66797860 |
| 119 | Melanogenesis_Homo sapiens_hsa04916 | 0.64388512 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.63263949 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62486503 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61833893 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61583851 |
| 124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61352238 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.61125551 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61055281 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60194858 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59422804 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58199478 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58037396 |
| 131 | Purine metabolism_Homo sapiens_hsa00230 | 0.58017311 |
| 132 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57874573 |
| 133 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57811888 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56929853 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56326009 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.55770391 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55637680 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55456237 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54596595 |
| 140 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54411172 |
| 141 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52757008 |
| 142 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51849304 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51130309 |
| 144 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50337621 |
| 145 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50193511 |
| 146 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47567530 |
| 147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46138398 |
| 148 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44929487 |
| 149 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44568827 |
| 150 | RNA polymerase_Homo sapiens_hsa03020 | 0.43605685 |
| 151 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42941437 |
| 152 | Proteasome_Homo sapiens_hsa03050 | 0.42909246 |
| 153 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42166129 |

